|
SUPT7L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.57788999999298E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.778730E-03 |
| Normal-vs-Stage2 |
2.603500E-02 |
| Normal-vs-Stage3 |
2.350000E-01 |
| Normal-vs-Stage4 |
9.843000E-01 |
| Stage1-vs-Stage2 |
2.261000E-01 |
| Stage1-vs-Stage3 |
7.101000E-01 |
| Stage1-vs-Stage4 |
2.916200E-01 |
| Stage2-vs-Stage3 |
1.977760E-01 |
| Stage2-vs-Stage4 |
1.607950E-01 |
| Stage3-vs-Stage4 |
5.394200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.22390000000395E-05 |
| Normal-vs-AfricanAmerican |
1.005550E-02 |
| Normal-vs-Asian |
1.071990E-01 |
| Caucasian-vs-AfricanAmerican |
9.756600E-01 |
| Caucasian-vs-Asian |
4.611800E-01 |
| AfricanAmerican-vs-Asian |
4.851400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.183700E-04 |
| Normal-vs-Female |
8.2791000000082E-05 |
| Male-vs-Female |
1.328020E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.738360E-01 |
| Normal-vs-Extreme_Weight |
5.679800E-02 |
| Normal-vs-Obese |
2.284100E-03 |
| Normal-vs-Extreme_Obese |
1.611200E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.868000E-01 |
| Normal_Weight-vs-Obese |
2.737000E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.538600E-01 |
| Extreme_Weight-vs-Obese |
1.634000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.712800E-01 |
| Obese-vs-Extreme_Obese |
8.923800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.631540E-04 |
| Normal-vs-Age(41-60Yrs) |
8.67939999982248E-07 |
| Normal-vs-Age(61-80Yrs) |
8.698000E-03 |
| Normal-vs-Age(81-100Yrs) |
6.232200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.668800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.034300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.777200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.591700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.854050E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.918210E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.92989999933968E-08 |
| Normal-VS-Type2 PRCC |
8.316400E-01 |
| Normal-VS-KIRP CIMP |
9.484800E-01 |
| Normal-VS-Unclassified PRCC |
5.942900E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.031600E-04 |
| Type1 PRCC-VS-KIRP CIMP |
8.647500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.181600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.662800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.419600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.324250E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.140200E-01 |
| Normal-vs-N1 |
7.006000E-02 |
| Normal-vs-N2 |
4.940000E-01 |
| N0-vs-N1 |
1.463360E-01 |
| N0-vs-N2 |
2.603600E-01 |
| N1-vs-N2 |
2.693400E-01 |
|
|
